The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...
A collaboration between a rural, urgent care center network and diagnostics company may be laying the groundwork for speeding ...
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Researchers from the Southern University of Science and Technology, reporting on November 28, 2025, in Microsystems & Nanoengineering, describe a new optoelectrowetting-based droplet dispensing system ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...
WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
QIAGEN shares decline as Q4 earnings meet estimates and revenues beat, with margin contraction and cautious 2026 guidance in ...
Qiagen (QGEN) reported $540.42 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 3.7%. EPS of $0.62 for the same period compares to $0.64 a year ago.
A pilot study has found evidence of Bartonella and Babesia infection in almost half of 50 blood samples from patients suffering chronic fatigue syndrome, also called myalgic encephalomyelitis (ME).
Explore how biochemistry, microbiology, and pathology collaborate in cancer care for early detection, personalized treatment, and survival monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results